Shideh Majidi1, Holly K O'Donnell1, Kelly Stanek1, Erin Youngkin1, Tara Gomer1, Kimberly A Driscoll2,3. 1. Barbara Davis Center for Diabetes, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO. 2. Barbara Davis Center for Diabetes, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO k.driscoll@phhp.ufl.edu. 3. Department of Clinical and Health Psychology, College of Public Health and Health Professions, University of Florida, Gainesville, FL.
Abstract
OBJECTIVE: To describe sociodemographic and clinical characteristics of youth and young adults with type 1 diabetes who endorsed suicidal ideations as part of routine depression screening and the results of their suicide risk assessments. RESEARCH DESIGN AND METHODS: The Patient Health Questionnaire-9 was used to assess depressive symptoms and suicide/death ideation in 550 youth and young adults with type 1 diabetes ages 10-24 years. Only individuals who endorsed suicidal/death ideations (n = 49) completed a standardized suicide risk assessment protocol and safety planning. RESULTS: Nine percent of individuals endorsed suicidal/death ideation and of those, 83.4% reported clinically elevated depressive symptoms; 16% made a previous suicide attempt. No youth (n = 39) or young adults (n = 11) disclosed current plans or preparations for suicide, but five who expressed suicidal ideation acknowledged the lethality of insulin for an attempt. Three previously used insulin to attempt suicide. The overwhelming majority of individuals were classified as being low risk for future suicide attempt/completion. None were hospitalized as a part of the suicide risk assessment, and no suicide completions have occurred. CONCLUSIONS: The findings of this study provide initial insight into the behaviors and cognitions of youth and young adults with type 1 diabetes who experience suicidal and death ideations. Comprehensive suicide risk assessment and safety planning are feasible during routine type 1 diabetes clinic appointments.
OBJECTIVE: To describe sociodemographic and clinical characteristics of youth and young adults with type 1 diabetes who endorsed suicidal ideations as part of routine depression screening and the results of their suicide risk assessments. RESEARCH DESIGN AND METHODS: The Patient Health Questionnaire-9 was used to assess depressive symptoms and suicide/death ideation in 550 youth and young adults with type 1 diabetes ages 10-24 years. Only individuals who endorsed suicidal/death ideations (n = 49) completed a standardized suicide risk assessment protocol and safety planning. RESULTS: Nine percent of individuals endorsed suicidal/death ideation and of those, 83.4% reported clinically elevated depressive symptoms; 16% made a previous suicide attempt. No youth (n = 39) or young adults (n = 11) disclosed current plans or preparations for suicide, but five who expressed suicidal ideation acknowledged the lethality of insulin for an attempt. Three previously used insulin to attempt suicide. The overwhelming majority of individuals were classified as being low risk for future suicide attempt/completion. None were hospitalized as a part of the suicide risk assessment, and no suicide completions have occurred. CONCLUSIONS: The findings of this study provide initial insight into the behaviors and cognitions of youth and young adults with type 1 diabetes who experience suicidal and death ideations. Comprehensive suicide risk assessment and safety planning are feasible during routine type 1 diabetes clinic appointments.
Authors: Sarah D Corathers; Jessica Kichler; Nana-Hawa Yayah Jones; Andrea Houchen; Mary Jolly; Nancy Morwessel; Peggy Crawford; Lawrence M Dolan; Korey K Hood Journal: Pediatrics Date: 2013-10-14 Impact factor: 7.124
Authors: D B Goldston; A E Kelley; D M Reboussin; S S Daniel; J A Smith; R P Schwartz; W Lorentz; C Hill Journal: J Am Acad Child Adolesc Psychiatry Date: 1997-11 Impact factor: 8.829
Authors: Matthew K Nock; Jennifer Greif Green; Irving Hwang; Katie A McLaughlin; Nancy A Sampson; Alan M Zaslavsky; Ronald C Kessler Journal: JAMA Psychiatry Date: 2013-03 Impact factor: 21.596
Authors: Agnieszka Butwicka; Louise Frisén; Catarina Almqvist; Björn Zethelius; Paul Lichtenstein Journal: Diabetes Care Date: 2015-02-03 Impact factor: 19.112
Authors: Ashley C Moss; Alissa J Roberts; Joyce P Yi-Frazier; Kendra L Read; Craig E Taplin; Kathryn W Weaver; Catherine Pihoker; Irl B Hirsch; Faisal S Malik Journal: Diabetes Care Date: 2022-05-01 Impact factor: 17.152
Authors: Artur Myśliwiec; Maria Skalska; Arkadiusz Michalak; Jędrzej Chrzanowski; Małgorzata Szmigiero-Kawko; Agnieszka Lejk; Joanna Jastrzębska; Łukasz Radzimiński; Guillermo F López-Sánchez; Andrzej Gawrecki; Zbigniew Jastrzębski Journal: Int J Environ Res Public Health Date: 2021-01-15 Impact factor: 3.390
Authors: Ryan M Hill; Katherine A S Gallagher; Sahar S Eshtehardi; Serife Uysal; Marisa E Hilliard Journal: Curr Diab Rep Date: 2021-12-13 Impact factor: 4.810
Authors: Maureen Monaghan; Constance A Mara; Jessica C Kichler; Sarah C Westen; Alana Rawlinson; Laura M Jacobsen; Rebecca N Adams; Jenine Y Stone; Korey K Hood; Shelagh A Mulvaney Journal: Can J Diabetes Date: 2021-01-22 Impact factor: 2.774